1. Home
  2. SILO vs MGOL Comparison

SILO vs MGOL Comparison

Compare SILO & MGOL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SILO
  • MGOL
  • Stock Information
  • Founded
  • SILO 2010
  • MGOL 2018
  • Country
  • SILO United States
  • MGOL United States
  • Employees
  • SILO N/A
  • MGOL N/A
  • Industry
  • SILO Apparel
  • MGOL Advertising
  • Sector
  • SILO Consumer Discretionary
  • MGOL Consumer Discretionary
  • Exchange
  • SILO Nasdaq
  • MGOL Nasdaq
  • Market Cap
  • SILO 8.8M
  • MGOL 1.1M
  • IPO Year
  • SILO N/A
  • MGOL 2023
  • Fundamental
  • Price
  • SILO $1.65
  • MGOL $0.37
  • Analyst Decision
  • SILO
  • MGOL
  • Analyst Count
  • SILO 0
  • MGOL 0
  • Target Price
  • SILO N/A
  • MGOL N/A
  • AVG Volume (30 Days)
  • SILO 805.4K
  • MGOL 83.8M
  • Earning Date
  • SILO 02-18-2025
  • MGOL 03-31-2025
  • Dividend Yield
  • SILO N/A
  • MGOL N/A
  • EPS Growth
  • SILO N/A
  • MGOL N/A
  • EPS
  • SILO N/A
  • MGOL N/A
  • Revenue
  • SILO $72,102.00
  • MGOL $5,197,527.00
  • Revenue This Year
  • SILO $1.86
  • MGOL N/A
  • Revenue Next Year
  • SILO N/A
  • MGOL N/A
  • P/E Ratio
  • SILO N/A
  • MGOL N/A
  • Revenue Growth
  • SILO N/A
  • MGOL 47.01
  • 52 Week Low
  • SILO $0.77
  • MGOL $0.10
  • 52 Week High
  • SILO $4.50
  • MGOL $18.30
  • Technical
  • Relative Strength Index (RSI)
  • SILO 52.57
  • MGOL 24.70
  • Support Level
  • SILO $1.56
  • MGOL $0.10
  • Resistance Level
  • SILO $1.89
  • MGOL $0.14
  • Average True Range (ATR)
  • SILO 0.19
  • MGOL 0.05
  • MACD
  • SILO -0.05
  • MGOL 0.03
  • Stochastic Oscillator
  • SILO 27.12
  • MGOL 17.00

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

About MGOL MGO Global Inc.

MGO Global Inc has built a brand acceleration platform with a focus on the acquisition, optimization and monetization of consumer brands across multiple categories. Its mission is to provide customers with unmatched variety, quality and shopping experience. The Company has three reportable segments: 1) The Messi Store, which sells a range of products under The Messi Brand; 2) Stand Flagpoles, which sells a range of residential flagpoles and related products direct to consumers; and 3) Corporate, which generates no revenue, but reflects corporate expenses related primarily to being a public company.

Share on Social Networks: